BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1295463)

  • 21. Fluorescent location of brain tumour cells in wax embedded sections.
    Steven FS; Reid H
    Anticancer Res; 1992; 12(4):1179-82. PubMed ID: 1323948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The status of the surface enzyme guanidinobenzoatase on mature epithelial cells in sputum cell monolayers.
    Steven FS; Payne PW; Palcic B
    Anticancer Res; 1993; 13(2):311-5. PubMed ID: 8517644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of the cell surface protease guanidinobenzoatase.
    Steven FS; Griffin MM; Maier H; Talbot IC
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():89-94. PubMed ID: 2400591
    [No Abstract]   [Full Text] [Related]  

  • 24. The application of double fluorescence to the rapid selection of atypical cervical epithelial cells spread in monolayers.
    Steven FS; Johnson J; Eason P; Tomasic M; Palcic B
    Anticancer Res; 1993; 13(4):1069-73. PubMed ID: 8352527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.
    Steven F; Griffin MM; Williams LA; Feichter G
    Anticancer Res; 1988; 8(6):1179-83. PubMed ID: 3218954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of a protease associated with tumour cells and the probable mechanism of regulation of this interaction in vivo.
    Steven FS; Maier H; Arndt J
    J Enzyme Inhib; 1989; 3(2):145-57. PubMed ID: 2489235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and purification of a guanidinobenzoatase: a possible marker of human renal carcinoma.
    Poustis-Delpont C; Descomps R; Auberger P; Delque-Bayer P; Sudaka P; Rossi B
    Cancer Res; 1992 Jul; 52(13):3622-8. PubMed ID: 1617634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid technique for the fluorescent location of pleomorphic adenoma cells in frozen sections of human salivary glands.
    Steven FS; Griffin MM; Maier H; Born IA
    Anticancer Res; 1990; 10(1):91-6. PubMed ID: 2159255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of guanidinobenzoatase: evidence for multiple forms of this protease on different tumour cells.
    Steven FS; Griffin MM; Freemont AJ; Johnson J
    J Enzyme Inhib; 1988; 2(2):117-27. PubMed ID: 3236068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting adriamycin to tumour cells by means of an affinity ligand; a model system for drug delivery.
    Steven FS; Griffin MM; Williams LA; Ali H; Maier H
    Anticancer Res; 1989; 9(1):247-53. PubMed ID: 2705751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the induction of a tumour associated cell surface protease on cytologically normal epithelial cells present in the sputum of patients possessing lung tumours.
    Steven FS; Katsumi T; Payne PW; Denton J
    Anticancer Res; 1999; 19(4C):3491-3. PubMed ID: 10629641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dansyl fluoride, a fluorescent inhibitor for the location of tumour cells in human tissues.
    Anees M; Benbow EW
    J Enzyme Inhib; 1996; 10(3):195-201. PubMed ID: 8835945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for inhibitors of the cell surface protease guanidinobenzoatase.
    Steven FS; Griffin MM; Wong TL; Itzhaki S
    J Enzyme Inhib; 1986; 1(2):127-37. PubMed ID: 3508910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescent location of abnormal cells in cell smears obtained from the lungs of patients with lung cancer.
    Steven FS; Lam S; Macaulay C; Palcic B
    Anticancer Res; 1992; 12(3):625-9. PubMed ID: 1622117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct evidence for the cell surface location of a protease-inhibitor complex on intact leukaemia cells.
    Steven FS; Griffin MM
    J Enzyme Inhib; 1990; 3(4):311-6. PubMed ID: 2319334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective role of a natural inhibitor in the fluorescent location of cells possessing a latent form of cell surface protease.
    Steven FS; Williams LA
    J Enzyme Inhib; 1990; 3(4):317-22. PubMed ID: 1690794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescent location of malignant cells in smears obtained from sputum.
    Steven FS; Payne PW; Palcic B
    Anticancer Res; 1994; 14(5A):2021-4. PubMed ID: 7847845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential inhibition of a cell surface protease on normal and tumour cells.
    Steven FS; Benbow EW
    Anticancer Res; 1992; 12(2):393-7. PubMed ID: 1580556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of a cell surface protease after cisplatin chemotherapy.
    Steven FS; Zoeller J; Maier H; Born IA
    J Enzyme Inhib; 1991; 5(2):151-64. PubMed ID: 1669443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the stability of a tumour cell surface protease after exposure to 6N HCl.
    Steven FS; Denton J
    Anticancer Res; 1997; 17(2A):891-3. PubMed ID: 9137423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.